午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11973
88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

SR4554 167648-73-9
Felvizumab 167747-20-8
GNE-0946 1677667-24-1
(R)-VX-11e 1680187-43-2
Rosmantuzumab 1684393-04-1
αvβ1 integrin-IN-1 1689540-62-2
Flupyrimin 1689566-03-7
Obexelimab 1690307-05-1
Lanepitant 170566-84-4
ARTD10/PARP10-IN-1 1708103-76-7
1-vinylpyrene 17088-21-0
Frunevetmab 1708936-80-4
Emapalumab 1709815-23-5
Sodium zirconium cyclosilicate 17141-74-1
Igovomab 171656-50-1
tert-Butyl (6-iodohexyl)carbamate 172846-36-5
Inophyllum E 17312-31-1
(E)-3-(2-Chloro-4-fluorophenyl)acrylic acid 174603-37-3
BODIPY FL prazosin 175799-93-6
3,4,5-Trihydroxycinnamic acid decyl ester 1770778-45-4
Phenmedipham-d3 1773497-41-8
ATX-002 1777792-34-3
Sarizotan 2HCl 177976-12-4
Telisotuzumab 1781223-80-0
ML 120B dihydrochloride 1782573-78-7
FK 866 hydrochloride (658084-64-1 free base) 1785666-54-7
NLRP3/AIM2-IN-3 1787787-60-3
Gosuranemab 1788032-39-2
UC-781 178870-32-1
Nav1.7-IN-3 1788872-06-9
Basiliximab 179045-86-4
WAY-639228 179051-05-9
Remtolumab 1791410-27-9
Lutikizumab 1791411-57-8
Elezanumab 1791416-49-3
Dilpacimab 1791420-09-1
(2R,5S)-Ritlecitinib 1792180-79-0
Vunakizumab 1792181-33-9
SB-237376 179258-59-4
SB-237376 HCl 179258-62-9
Porgaviximab 1792982-55-8
SXC 2023 1695562-36-7
Nonabine 16985-03-8
Anisperimus 170368-04-4
AZ-PFKFB3-67 1704741-11-6
Lanepitant 2HCl 170508-05-1
Larcaviximab 1792982-56-9
ER-34122 179325-62-3
Netakimab 1796570-08-5
PF-04822163 1798334-07-2
GPR40 agonist 6 1798751-25-3
GNF6702 1799329-72-8
BCAT-IN-2 1800024-45-6
Gremubamab 1800381-36-5
Odronextamab 1801338-64-6
Cemiplimab 1801342-60-8
RYL-552S 1801444-69-8
Losatuxizumab 1801544-27-3
ABBV-318 1802848-94-7
RN-1665 1803003-65-7
Oleclumab 1803176-05-7
KL044 1801856-93-8
SR12418 1801185-08-9
Oleoylestrone 180003-17-2
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc 1799711-31-1
Sacituzumab 1796566-95-4
Cosfroviximab 1792982-57-0
NLRP3-IN-13 1704638-35-6
Cevidoplenib 1703788-21-9
DP00477 169120-56-3
Crizanlizumab 1690318-25-2
LDN-209929 dihydrochloride 1784281-97-5
RKI-1447 dihydrochloride 1782109-09-4
Opaviraline 178040-94-3
MMP2-IN-2 1772-39-0
Izonsteride 176975-26-1
Roxifiban acetate 176022-59-6
Tagatose 17598-81-1
Tidembersat 175013-73-7
Keliximab 174722-30-6
NDH-1 inhibitor-1 173964-49-3
Piprozolin 17243-64-0
YM-58790 168830-70-4
Dyrk1A-IN-5 1685235-41-9
Propofol-d17 β-D glucuronide 1683581-05-6
PG 34 1681056-62-1
DJ4 1681020-24-5
Ravulizumab 1803171-55-2
RYL-552 1801444-56-3
Vutiglabridin 1800188-47-9
GSK180 1799725-26-0
CCT245232 1693731-14-4
BMS-599626 2HCL(714971-09-2 Free base) 1781932-33-9
CYP1B1-IN-5 176442-56-1
Faralimomab 167816-91-3
Sulesomab 167747-19-5
ZY-444 1802650-31-2
Xanthine amine congener hydrochloride 1783977-95-6
Minzasolmin 1802518-92-8
Cynandione A 168706-29-4
88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.